Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association Between Intraprocedural Drops in Blood Pressure and Infarct Growth Rate Patterns After Acute Large-vessel Occlusions
Cerebrovascular Disease and Interventional Neurology
S34 - Stroke Risk Factors and Preventative Strategies (3:54 PM-4:06 PM)
003
IGR differs among patients with LVO-AIS, and mainly depends on the collateral circulation and brain hemodynamics. This variability has critical clinical repercussions that remain unclear. 
We explored  the association between infarct growth rate(IGR) patterns and blood pressure(BP) during endovascular therapy(EVT) in patients with acute ischemic stroke due to large vessel occlusion(LVO-AIS).

This two-center observational study included anterior circulation LVO-AIS patients who underwent EVT and achieved mTICI 2c-3. Initial and final infarct volumes(FIV) were defined using admission CTP defined as rCBF<30%, and DWI-MRI at 24 hours post-EVT. We categorized IGR patterns as exponential(ExpIGR) and Non-exponential(NonExp) based on their growth curves. We then dichotomized ExpIGR clinical significance based on the association of infarct growth with 90-day mRS as ExpIGR-A(>13 ml) and ExpIGR-B(<13 ml). Intraprocedural BP drops were calculated as the difference between MAP at admission and the lowest intraprocedural MAP reading before recanalization, and the area between admission MAP threshold and all lower measurements of intraprocedural MAP. Multivariable regression was used to investigate associations between variables of interest.

Of 159 TICI 2c-3 patients, 36% demonstrated ExpIGR-A, 31% ExpIGR-B, and 32.7% NonExp patterns. The Exp-A and Exp-B groups differed significantly in NIHSS, ASPECTS, glucose, and FIV. The Exp-A and NonExp groups differed in rCBF<30% volume, and stroke onset-to-admission CTP-time. The Exp-B and NonExp groups in NIHSS, rCBF<30%, Tmax<6s, collateral flow measured by hypoperfusion intensity ratio(HIR), and FIV. Hypotensive MAP area(HMA) was independently associated with an ExpIGR-A pattern. Infarct volume increased by 1ml per 100 units of hypotensive area and 4.2ml per 0.1 units of HIR, with a significant interaction between both variables.

After an LVO-AIS, IGR can be differentiated into exponential and non-exponential patterns. A subgroup of patients with the exponential experienced clinically significant IGR increase between CTP acquisition and reperfusion and seemed to be vulnerable to sustained intraprocedural BP drops during EVT.

Authors/Disclosures
Milagros Galecio-Castillo, MD (University of Iowa Hospitals and Clinics)
PRESENTER
Dr. Galecio-Castillo has nothing to disclose.
Darko E. Quispe Orozco, MD (TTUHSC-SOM, Lubbock; Neurology Dept.) Dr. Quispe Orozco has nothing to disclose.
Andres Dajles (University of Iowa) No disclosure on file
Yelyzaveta Begunova Miss Begunova has nothing to disclose.
Aaron E. Rodriguez-Calienes (University of Iowa Hospitals and Clinics) Dr. Rodriguez-Calienes has nothing to disclose.
Juan A. Vivanco-Suarez, MD Mr. Vivanco-Suarez has nothing to disclose.
Mahmoud Dibas (Sulaiman Al Rajhi Colleges) Mr. Dibas has nothing to disclose.
Nils Petersen, MD (Yale University) Dr. Petersen has received research support from NIH.
Santiago Ortega Gutierrez, MD (University of Iowa) Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.